Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Class A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
99,823,000
-
Total 13F shares
-
3,609,389
-
Share change
-
-210,078
-
Total reported value
-
$4,577,211
-
Put/Call ratio
-
251%
-
Price per share
-
$1.26
-
Number of holders
-
38
-
Value change
-
-$332,794
-
Number of buys
-
14
-
Number of sells
-
13
Institutional Holders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) as of Q1 2025
As of 31 Mar 2025,
Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,609,389 shares.
The largest 10 holders included
VANGUARD GROUP INC, Nan Fung Group Holdings Ltd, Alphabet Inc., UNITED SERVICES AUTOMOBILE ASSOCIATION, TAKEDA PHARMACEUTICAL CO LTD, GEODE CAPITAL MANAGEMENT, LLC, KESTRA PRIVATE WEALTH SERVICES, LLC, NORTHERN TRUST CORP, CWA Asset Management Group, LLC, and UBS Group AG.
This page lists
38
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.